Company: CDT
Filing Date: 2025-07-08
Form Type: DEF 14A
Source: 0001641172-25-018242
Chunk: 11

Company: CDT Equity Inc.
Filing Date: 2025-07-08
Form: DEF 14A
Chunk 11
---
 has served as a board member of Old Conduit since 2019. Dr. Regan also founded
Corvus Capital Limited and has been its Chief Executive Officer since 2008. Corvus Capital is an investment vehicle that was previously
listed on the London Stock Exchange prior to being taken private in 2008. Corvus Capital continues to invest in a number of industries
and sectors. Dr. Regan also has experience as an investor in a number of public and private companies, including ASOS.com Ltd, a global
online fashion and beauty retailer, Virtual Internet, an IT services company that specializes in hosting infrastructure such as VMWare
cloud hosting and Managed and Dedicated Servers, and Imperial Energy Corporation plc, an upstream oil and gas exploration and production
company. Prior to that, Dr. Regan was the Chief Executive Officer of Hobson Plc, which was listed on the London Stock Exchange, until
its sale in 1996 through a cash takeover. Dr. Regan has a strong interest in the use of bio-inspired science to create solutions for
present day problems. In 2014, he was awarded a PhD from Oxford Brookes University for his research in writing and developing a bio-inspired
algorithm for forecasting the financial markets. He is passionate about the polar regions and is an accomplished polar explorer having
led a number of expeditions to both the Arctic and Antarctica. Dr. Regan was selected to serve on our board of directors following the
Business Combination based on his knowledge of Old Conduit and his extensive experience in investing, financing, overseeing and developing
companies.

Freda Lewis-Hall, M.D., DFAPA. Dr. Lewis-Hall has served as a member of our Board since September 2023. She served as senior medical advisor to the CEO of Pfizer Inc., or Pfizer, from December 2019 until her retirement in March 2020. Before assuming that responsibility, beginning January 2019, Dr. Lewis-Hall served as Chief Patient Officer and Executive Vice President of Pfizer. Dr. Lewis-Hall served as Pfizer’s Chief Medical Officer from 2009 to January 2019. Prior to joining Pfizer in 2009, Dr. Lewis-Hall held various senior leadership positions including Chief Medical Officer and Executive Vice President, Medicines Development at Vertex Pharmaceuticals Incorporated from June 2008 to May 2009; Senior Vice President, U.S. Pharmaceuticals, Medical Affairs for Bristol-Myers Squibb Company from 2003 until May 2008